# Clinical Cases: GI Secretion

## Case 1: Zollinger-Ellison Syndrome

### Patient Presentation
**Demographics:** 48-year-old male

**Chief Complaint:** Recurrent peptic ulcers and chronic diarrhea

**History of Present Illness:** The patient has had three separate episodes of peptic ulcer disease over the past 4 years, requiring hospitalization twice for upper GI bleeding. He reports persistent epigastric burning despite continuous high-dose PPI therapy. He also experiences 4-5 watery, non-bloody stools daily and has lost 15 pounds over the past year. He tested negative for H. pylori on multiple occasions.

**Past Medical History:** No prior medical conditions before ulcer disease onset

**Family History:** Father diagnosed with kidney stones at age 50

### Physical Examination
- **Vital Signs:** BP 124/78 mmHg, HR 76 bpm, BMI 23
- **General:** Thin male, appears uncomfortable
- **Abdomen:** Mild epigastric tenderness, no peritoneal signs, no palpable masses
- **Skin:** No rashes

### Workup and Results
- **Upper Endoscopy:** Multiple duodenal ulcers (D1 and D2), one jejunal ulcer (unusual location)
- **Fasting Serum Gastrin:** 1,850 pg/mL (normal <100 pg/mL)
- **Gastric pH:** 1.2 (low pH excludes achlorhydria as cause of hypergastrinemia)
- **Secretin Stimulation Test:** Paradoxical gastrin rise of 280 pg/mL (diagnostic)
- **CT Abdomen:** 2.1 cm mass in the pancreatic head
- **EUS with FNA:** Neuroendocrine tumor confirmed

![Gastrinoma CT](case_01_image.jpg)
*CT scan showing a hypervascular mass in the pancreatic head (arrow) within the gastrinoma triangle, consistent with a gastrin-secreting neuroendocrine tumor.*

**Image Source:** Case courtesy of Radiopaedia.org

### Diagnosis
**Zollinger-Ellison Syndrome (Gastrinoma)**

### Clinical Correlation to Gastric Secretion Physiology
Gastrinomas autonomously secrete gastrin, bypassing normal feedback regulation. Normally, low gastric pH (<3) stimulates somatostatin release from D cells, which inhibits gastrin release from G cells. Gastrinomas are not subject to this feedback. The resulting hypergastrinemia causes massive stimulation of parietal cells, producing acid hypersecretion. This explains multiple ulcers, ulcers in unusual locations (distal duodenum, jejunum where acid overcomes buffering capacity), and refractory symptoms despite PPIs. Diarrhea occurs because excess acid inactivates pancreatic lipase and damages small intestinal mucosa. The secretin stimulation test is diagnostic because secretin normally inhibits gastrin release, but paradoxically stimulates gastrinomas.

### Treatment
- High-dose PPI (often 2-3 times standard dose) for acid control
- Surgical resection of localized tumor for potential cure
- Screen for MEN1 (parathyroid hormone, calcium, prolactin)
- Somatostatin analogs (octreotide) for unresectable disease
- Long-term surveillance for metastatic disease

---

## Case 2: Cholera (Secretory Diarrhea)

### Patient Presentation
**Demographics:** 32-year-old male

**Chief Complaint:** Severe watery diarrhea for 18 hours

**History of Present Illness:** The patient recently returned from a humanitarian trip to Bangladesh 3 days ago. He developed sudden onset of profuse watery diarrhea, initially with cramping that resolved as diarrhea progressed. He estimates passing 15-20 stools in the past day. The stool has a "rice-water" appearance without blood or mucus. He also has muscle cramps and feels extremely weak.

**Past Medical History:** Healthy, no prior illnesses

**Social History:** Traveled to rural Bangladesh, consumed local food and water

### Physical Examination
- **Vital Signs:** BP 78/50 mmHg, HR 132 bpm, Temperature 37.0C, RR 24/min
- **General:** Lethargic, severely dehydrated male
- **HEENT:** Sunken eyes, dry mucous membranes, poor skin turgor
- **Cardiovascular:** Tachycardic, weak pulses
- **Abdomen:** Soft, mild diffuse tenderness, hyperactive bowel sounds

### Workup and Results
- **Chemistry:** Na 152 mEq/L, K 2.4 mEq/L, Cl 118 mEq/L, HCO3 12 mEq/L, BUN 58 mg/dL, Cr 2.8 mg/dL
- **Stool Analysis:** Watery, no blood or WBCs, positive for Vibrio cholerae on culture
- **ABG:** pH 7.18, metabolic acidosis with anion gap 22

![Cholera Mechanism](case_02_image.jpg)
*Diagram illustrating the mechanism of cholera toxin causing secretory diarrhea through irreversible activation of Gs protein and adenylyl cyclase, leading to continuous CFTR-mediated chloride secretion.*

**Image Source:** Wikimedia Commons, Public Domain

### Diagnosis
**Cholera (Vibrio cholerae infection)**

### Clinical Correlation to Intestinal Secretion Physiology
Cholera toxin enters intestinal epithelial cells and irreversibly activates the Gs alpha subunit that stimulates adenylyl cyclase. The resulting massive, sustained increase in cAMP continuously activates CFTR chloride channels on the apical membrane. Chloride secretion into the lumen creates an electrical gradient drawing sodium paracellularly, and water follows osmotically. This produces secretory diarrhea that can exceed 10-20 liters daily. Critically, glucose-coupled sodium absorption via SGLT1 remains functional even when chloride secretion is maximally stimulated. This is the physiologic basis for oral rehydration solution (ORS), which provides glucose and sodium together to drive sodium and water absorption despite ongoing secretion.

### Treatment
- Aggressive IV fluid resuscitation (Lactated Ringer's or normal saline)
- Oral rehydration solution (ORS) when able to tolerate
- Potassium replacement
- Antibiotics (doxycycline or azithromycin) to reduce duration and shedding
- Monitor for renal recovery and electrolyte normalization

---

## Case 3: Chronic Pancreatitis with Exocrine Insufficiency

### Patient Presentation
**Demographics:** 52-year-old male

**Chief Complaint:** Chronic abdominal pain, greasy stools, and weight loss

**History of Present Illness:** The patient reports 10 years of episodic epigastric pain radiating to the back, initially occurring after alcohol intake but now constant and requiring daily opioid analgesics. Over the past 2 years, he has developed oily, foul-smelling stools that are difficult to flush (3-4 per day). He has lost 30 pounds despite eating normally. He reports occasional symptoms of hypoglycemia.

**Past Medical History:** Recurrent acute pancreatitis (4 episodes over 12 years)

**Social History:** Heavy alcohol use for 25 years (6-8 beers daily, recently reduced), 30 pack-year smoking history

### Physical Examination
- **Vital Signs:** BP 118/74 mmHg, HR 80 bpm, BMI 19
- **General:** Thin, cachectic male
- **Abdomen:** Epigastric tenderness, no masses, no peritoneal signs
- **Extremities:** Muscle wasting

### Workup and Results
- **CT Abdomen:** Pancreatic calcifications, dilated pancreatic duct with "chain of lakes" appearance, parenchymal atrophy
- **Fecal Elastase:** 85 mcg/g (normal >200 mcg/g, indicating severe exocrine insufficiency)
- **HbA1c:** 7.8% (new diabetes)
- **Fat-soluble Vitamins:** Vitamin D 12 ng/mL (low), Vitamin A low-normal

![Chronic Pancreatitis CT](case_03_image.jpg)
*CT scan demonstrating pancreatic calcifications (arrows) and ductal dilation characteristic of chronic pancreatitis with parenchymal atrophy.*

**Image Source:** Case courtesy of Radiopaedia.org

### Diagnosis
**Chronic Pancreatitis with Exocrine and Endocrine Insufficiency**

### Clinical Correlation to Pancreatic Secretion Physiology
Chronic pancreatitis causes progressive destruction of acinar cells that produce digestive enzymes. Steatorrhea (fatty stools) develops only when exocrine function falls below 10% of normal, as the pancreas has significant reserve capacity. Without adequate pancreatic lipase (and its essential cofactor colipase), dietary triglycerides cannot be hydrolyzed to fatty acids and monoglycerides for micellar solubilization and absorption. The malabsorbed fat creates bulky, malodorous stools that float. Fat-soluble vitamin deficiencies (A, D, E, K) develop because these vitamins require fat absorption. Loss of bicarbonate-secreting duct cells contributes to maldigestion by failing to neutralize gastric acid in the duodenum. Endocrine insufficiency (diabetes) develops as islets are destroyed; this "pancreatogenic diabetes" is particularly brittle due to concurrent glucagon deficiency.

### Treatment
- Absolute alcohol abstinence and smoking cessation
- Pancreatic enzyme replacement therapy (PERT) with meals (high-lipase formulations)
- Fat-soluble vitamin supplementation
- Low-fat diet for symptom control
- Diabetes management (typically insulin required)
- Pain management with non-opioid approaches when possible